In PCNA+ human melanoma, infiltrating pDCs showed increased NKp44 levels, which correlated with a low activation level, suggesting that the interaction of NKp44 with PCNA expressed by melanoma cells could contribute to pDC dysfunctions typically observed in melanoma patients. This evidence concerns the gene NCR2 and melanoma.